Top Abstract Purchase Related
Home
>
Node
>
Subnode

Endoscopic augmentation of neurogenic bladder with botulinum-A toxin in children

Kroll, P.ł; Jankowski, A.; Zachwieja, J.; Zaniew, M.; Mańkowski, P.ła.; Harasymczuk, J.; Antczak, A.; Murias, M.

Polski Merkuriusz Lekarski Organ Polskiego Towarzystwa Lekarskiego 24(Suppl 4): 15-17

2008

ISSN/ISBN: 1426-9686
PMID: 18924493
Document Number: 619485
To present our experience with endoscopic intradetrusor injections of botulinum-A toxin. Endoscopic treatment was proposed for children in which no improvement or side effects were observed. Botulinum-A toxin was injected in 25 children 3 to 7 years old. All children were evaluated with voiding-charts, in all of them urodynamic investigations were also performed in the pre and post-procedure period. Increased bladder volume was found in 18 patients, in 5 children bladder volume decreased. No major side effects were noted post BTX injections. Botulinum-A toxin in useful in children with neurogenic bladder overactivity.

Document emailed within 1 workday
Secure & encrypted payments

2013: Botulinum toxin type A and neurogenic urinary incontinence: sometimes beneficial, if used safely Prescrire International 22(134): 12-13
Brown, M. 2016: Preventing, identifying, and managing cosmetic procedure complications, part 1: soft-tissue augmentation and botulinum toxin injections Cutis 97(6): E28-E29
Chuang, Y-Chi.; Smith, C.P.; Somogyi, G.T.; Chancellor, M.B. 2003: Botulinum toxin treatment of urethral and bladder dysfunction Journal of the Formosan Medical Association 102(1): 5-11
Sherif, H.; Khalil, M.; Omar, R. 2017: Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation Canadian Journal of Urology 24(3): 8838-8846
Tengtrisorn, S.; Treyapun, N.; Tantisarasart, T. 2002: Botulinum a toxin therapy on esotropia in children Journal of the Medical Association of Thailand 85(11): 1189-1197
Anosov, I.I.; Bulatova, T.I. 1983: Morphological and histochemical reactions of an organism to the administration of Clostridium botulinum toxin. IX. Reactions of the neurons of the abducens nerve nucleus and of the Darkshevich's nucleus to the administration of C. botulinum type B toxin Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2: 101-105
Cibis, G.W.; Waeltermann, J. 1985: Botulinum isn't just a poison anymore. Botulinum toxin in treatment of strabismus and essential blepharospasm Missouri Medicine 82(3): 145-147
Sipp, J.A.; Haver, K.E.; Masek, B.J.; Hartnick, C.J. 2007: Botulinum toxin A: a novel adjunct treatment for debilitating habit cough in children Ear Nose and Throat Journal 86(9): 570-572
Prutthipongsit, A.; Aui-aree, N. 2015: The Difference of Treatment Results between Botulinum Toxin a Split Injection Sites and Botulinum Toxin a Non-Split Injection Sites for Hemifacial Spasm Journal of the Medical Association of Thailand 98(11): 1119-1123
Martinez-Castrillo, J.C.; Pena-Segura, J.L.; Sanz-Cartagena, P.; Alonso-Curco, X.; Arbelo-Gonzalez, J.M.; Arriola-Pereda, G.; Coll-Bosch, M.D.; Conejero-Casares, J.A.; Garcia-Ribes, A.; Jauma-Classen, S.; Pagonabarraga, J.; Vidal-Valls, J.; Garcia-Ruiz, P.J. 2017: Myths and evidence on the use of botulinum toxin: spasticity in adults and in children with cerebral palsy Revista de Neurologia 64(10): 459-470
Tjaberg, T.B. 1974: Proteases of Clostridium botulinum. VI. the role of trypsin, Clostridium botulinum proteases and protease inhibitors in the formation and activation of toxin in growing cultures of Clostridium botulinum Acta Veterinaria Scandinavica 15(4): 487-506
Simpson, L.L. 1984: The binding fragment from tetanus toxin antagonizes the neuromuscular blocking actions of botulinum toxin Journal of Pharmacology and Experimental Therapeutics 229(1): 182-187
Pascual-Pascual, S.I. 2003: Use of botulinum toxin in the preventive and palliative treatment of the hips in children with infantile cerebral palsy Revista de Neurologia 37(1): 80-82
Zürcher, A.W.; Molenaers, G.; Desloovere, K.; Fabry, G. 2001: Kinematic and kinetic evaluation of the ankle after intramuscular injection of botulinum toxin a in children with cerebral palsy Acta Orthopaedica Belgica 67(5): 475-480
Van Campenhout, A.; Bar-On, L.; Desloovere, K.; Molenaers, G. 2015: Role of motor end plate-targeted Botulinum toxin type a injections in children with cerebral palsyitle Acta Orthopaedica Belgica 81(2): 167-171
Zmanovskaia, V.A.; Levitina, E.V.; Popkov, D.A.; Butorina, M.N.; Pavlova, O.L. 2014: Botulinum toxin type a (dysport) in the complex rehabilitation of children with spastic forms of cerebral palsy Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(7): 33-36
Mollard, P.; Gelet, A.; Maréchal, J.M. 1978: Antireflux operation for neurogenic bladder in children (28 reimplantations) Chirurgie Pediatrique 19(1): 9-14
Perlmutter, A.D. 1979: Experiences with urinary undiversion in children with neurogenic bladder Transactions of the American Association of Genito-Urinary Surgeons 71: 134-139
Festge, O.A.; Tischer, W.; Schwock, G.; Uflacker, R. 1976: Diagnosis of neurogenic bladder-emptying disorders in children Zeitschrift für Arztliche Fortbildung 70(2): 49-53
Kanellopoulos, A.D.; Mavrogenis, A.F.; Mitsiokapa, E.A.; Panagopoulos, D.; Skouteli, H.; Vrettos, S.G.; Tzanos, G.; Papagelopoulos, P.J. 2009: Long lasting benefits following the combination of static night upper extremity splinting with botulinum toxin a injections in cerebral palsy children European Journal of Physical and Rehabilitation Medicine 45(4): 501-506